logo-loader

Full interview: Zelira Therapeutics on recent acquisition with Ilera

Published: 23:50 01 Dec 2019 GMT

Zelira Therapeutics Ltd (ASX:ZLD) founder and chairman Osagie Imasogie and deputy chairman Harry Karelis speaks to Proactive on the recent acquisition of Ilera Therapeutics LLC. 

Following overwhelming shareholder support, the merger will create a global medicinal cannabis company called Zelira Therapeutics Limited. 

The merger will bring together a portfolio of revenue-generating medicines and products undergoing clinical development that are expected to enter the market from 2020. 

Caledonia Mining tackles 2023 challenges with optimism for 2024 as it...

Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) chief executive Mark Learmonth tells Proactive's Stephen Gunnion the company faced a challenging 2023, primarily due to poor production in the first half of the year at its core asset, the Blanket Mine in Zimbabwe, and an underperformance...

1 hour, 29 minutes ago